We are live on ! Find out more
MLICM

Metropolitan Life Insurance Company (MetLife) Portfolio holdings

AUM $328M
1-Year Est. Return 9.77%
This Fund
S&P 500
This Quarter Est. Return
+8.93%
1 Year Est. Return
+9.77%
3 Year Est. Return
+50.33%
5 Year Est. Return
+74.21%
10 Year Est. Return
+345.05%
AUM
$7.1B
AUM Growth
+$407M
Cap. Flow
-$92.2M
Cap. Flow %
-1.3%
Top 10 Hldgs %
23.68%
Holding
2,973
New
384
Increased
1,273
Reduced
905
Closed
264

Sector Composition

Rank Sector Weight
1 Technology 22.98%
2 Consumer Discretionary 12.04%
3 Financials 12.03%
4 Healthcare 11.82%
5 Industrials 8.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GTBP icon
2251
GT Biopharma
GTBP
$10.7M
$136K ﹤0.01%
+293
New +$122K
IESC icon
2252
IES Holdings
IESC
$14.9B
$136K ﹤0.01%
2,639
KDNY
2253
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$135K ﹤0.01%
+9,583
New +$153K
RBB icon
2254
RBB Bancorp
RBB
$466M
$135K ﹤0.01%
5,573
OPRT icon
2255
Oportun Financial
OPRT
$351M
$135K ﹤0.01%
6,727
AGL icon
2256
Agilon Health
AGL
$1.49B
$135K ﹤0.01%
+133
New +$117K
NAT icon
2257
Nordic American Tanker
NAT
$1.4B
$134K ﹤0.01%
40,948
+18,130
+79% +$61.3K
UFPT icon
2258
UFP Technologies
UFPT
$2.48B
$134K ﹤0.01%
2,333
HAFC icon
2259
Hanmi Financial
HAFC
$963M
$134K ﹤0.01%
7,019
-2,351
-25% -$48.2K
BXC icon
2260
BlueLinx
BXC
$705M
$134K ﹤0.01%
+2,659
New +$131K
ORC
2261
Orchid Island Capital
ORC
$1.32B
$134K ﹤0.01%
5,150
+2,832
+122% +$78.7K
BOC icon
2262
Boston Omaha
BOC
$431M
$134K ﹤0.01%
4,213
IMDX
2263
Insight Molecular Diagnostics
IMDX
$121M
$133K ﹤0.01%
1,162
+134
+13% +$13.1K
OIS icon
2264
Oil States International
OIS
$526M
$133K ﹤0.01%
16,950
+7,278
+75% +$48.7K
RVI
2265
DELISTED
Retail Value Inc. Common Shares
RVI
$133K ﹤0.01%
66,543
+48,393
+267% +$86K
PAVM icon
2266
PAVmed
PAVM
$33.9M
$132K ﹤0.01%
+46
New +$109K
CLFD icon
2267
Clearfield
CLFD
$390M
$132K ﹤0.01%
3,514
BFC icon
2268
Bank First Corp
BFC
$1.76B
$131K ﹤0.01%
1,881
+1
+0.1% +$71
UI icon
2269
Ubiquiti
UI
$35.3B
$131K ﹤0.01%
419
-110
-21% -$32.2K
DLB icon
2270
Dolby
DLB
$5.84B
$131K ﹤0.01%
1,328
-365
-22% -$36.1K
FSLY icon
2271
Fastly Inc
FSLY
$4.78B
$130K ﹤0.01%
2,186
-3,545
-62% -$201K
OUST icon
2272
Ouster
OUST
$3.25B
$130K ﹤0.01%
+1,041
New +$111K
CIO
2273
DELISTED
City Office REIT
CIO
$130K ﹤0.01%
10,438
-7,309
-41% -$84.7K
DRRX
2274
DELISTED
DURECT Corp
DRRX
$130K ﹤0.01%
7,954
+4,759
+149% +$83K
RRD
2275
DELISTED
RR Donnelley & Sons Co.
RRD
$130K ﹤0.01%
+20,636
New +$113K

Similar funds

Metropolitan Life Insurance Company (MetLife)'s Q2 2021 Portfolio in Review

As of Q2 2021, Metropolitan Life Insurance Company (MetLife) held 2,973 positions worth $7.1B, up 6.1% from $6.69B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Metropolitan Life Insurance Company (MetLife)'s Q2 2021 filing shows 384 new, 1,273 increased, 905 reduced and 264 closed positions. Its largest new stake was Palantir: 112,538 shares worth $2.97M. The largest sale was Alphabet (Google) Class C, an estimated $96.8M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Metropolitan Life Insurance Company (MetLife)'s largest Q2 2021 buy was Palantir: 112,538 shares worth $2.97M.
  • Metropolitan Life Insurance Company (MetLife) added most to State Street SPDR S&P 500 ETF Trust in Q2 2021, an estimated $33.8M increase.
  • Metropolitan Life Insurance Company (MetLife)'s biggest Q2 2021 reduction was UnitedHealth, cutting an estimated $16M.
  • Metropolitan Life Insurance Company (MetLife) fully exited Alphabet (Google) Class C in Q2 2021, selling an estimated $96.8M.
  • Metropolitan Life Insurance Company (MetLife)'s ten largest holdings make up 24% of its $7.1B portfolio in Q2 2021.
  • Metropolitan Life Insurance Company (MetLife) opened 384 new positions and closed 264 in Q2 2021.
  • Metropolitan Life Insurance Company (MetLife)'s portfolio value rose 6.1% quarter-over-quarter to $7.1B.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2021, filed 16 Aug 2021.